Executive Search

Biotechnology

Latest Mandates

Associate/Senior Analyst, Structured Finance & Credit Analysis, Global Investment Bank, Moscow

Requirements

FICCInvestment BankingCEEMEARussia/CISAssociateAnalystMoscow2-6 Years Experience

Experience

ResearchStructured FinanceSpecial SituationsRestructuringLeveraged FinanceFixed IncomeFinancingDistressedCreditCoverageCorporatesCommoditiesChemicalsPetrochemicalsGeneralistEnergyGoldIndustrialsMetals & MiningNatural ResourcesOil & GasTechnologyTelecomsTMTTransportUtilitiesInfrastructureBasic MaterialsAgricultureReal EstateConsumerBiotechnologyHealthcareFintechRussian - Native

Responsibilities

AnalysisClient CoverageExecutionValuationDue DiligencePresentationModellingResearch
  • One of our Global Investment Banking clients are looking to hire a Associate/Senior Analyst Credit individual for their Structured Finance team in Moscow
  • The ideal candidate will have between 2-6 years of experience from a top tier financial institution, with expertise in Structured Finance, Leveraged Finance, Structuring, Special Situations, Credit Analysis and/or Credit Trading
  • The individual will be involved in all aspects of the transaction process, including: due diligence, financial modelling, credit analysis, pricing and term sheet preparation, coordinating internal approvals & documentation within the group
  • Fluency in Russian is mandatory

Lead Analyst, Biotechnology & Pharmaceutical, Public Equity Investments, Middle Eastern Sovereign Wealth Fund

Requirements

Asset ManagementUSAsiaEuropeAssociateVice PresidentDoha5-7 Years Experience

Experience

EquitiesMENA/GCCCapital MarketsPrincipal FinanceBiotechnologyHealthcare

Responsibilities

AnalysisDue DiligenceInvestingResearchPresentation
  • Public Equities Department of a Middle Eastern Sovereign Wealth Fund looking to hire an Analyst to lead investments in Biotech and Pharma subsectors
  • Team is growing a concentrated portfolio of investments in high quality large- and mid-cap companies in the US, APAC, and Europe
  • Candidates should have experience in investment roles at an asset management firm or in an equity research role at a top sell-side institution
  • 5-7 years experience with preference for individuals who have passed CFA or Chartered Accounting qualifications

Portfolio Manager, Biotechnology & Pharmaceutical, Public & Private Equity Investments, Middle Eastern Sovereign Wealth Fund

Requirements

Asset ManagementPrivate EquityUSAsiaEuropePortfolio ManagerDoha7-15 Years Experience

Experience

EquitiesInvestment BankingMENA/GCCCapital MarketsPrincipal FinanceBiotechnologyHealthcare

Responsibilities

AnalysisDue DiligenceInvestingResearchPresentation
  • Middle Eastern Sovereign Wealth Fund looking to hire a Director or Vice President to lead investments in the Pharma and Biotech subsectors as part of the Healthcare Investment Department
  • Role will include investing across asset classes including Public Equities, Private Equity & Venture Capital, Debt and Royalty streams, with a focus on the US, APAC, and Europe
  • Candidates should have at least 7 years experience across asset management, private equity, equity research or investment banking roles
  • Preference for individuals with an advanced Life Sciences degree (MD, PhD, etc.)

Chief Investment Officer, Listed Equities, Family Office, Dubai

Requirements

Asset ManagementEuropeEMEAMENA/GCCTurkeyCIOPortfolio ManagerManaging DirectorDirectorDubai15-20 Years Experience

Experience

ManagementHealthcareBiotechnologyFinancialsTechnologyFintechIndustrials

Responsibilities

Team ManagementDue Diligence
  • A multi-billion dollar single family office is looking to add a senior professional to lead investments into primarily non-Emerging Markets listed equities across healthcare, technology, financials and industrial sectors to be based in Dubai
  • The individual will source and evaluate investment ideas, manage a team of investment analysts, and report directly to the family principal
  • Candidates must have extensive experience in fundamental analysis at a similar buy-side institution
No longer available